A detailed history of Royal Bank Of Canada transactions in Xoma Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 4,883 shares of XOMA stock, worth $132,475. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,883
Previous 1,538 217.49%
Holding current value
$132,475
Previous $36,000 258.33%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.1 - $29.85 $77,269 - $99,848
3,345 Added 217.49%
4,883 $129,000
Q2 2024

Aug 14, 2024

BUY
$22.31 - $26.7 $9,258 - $11,080
415 Added 36.95%
1,538 $36,000
Q1 2024

Nov 05, 2024

SELL
$19.1 - $26.32 $7,926 - $10,922
-415 Reduced 26.98%
1,123 $27,000
Q1 2024

May 15, 2024

SELL
$19.1 - $26.32 $64,481 - $88,856
-3,376 Reduced 75.04%
1,123 $27,000
Q4 2023

Feb 14, 2024

BUY
$13.82 - $19.13 $31,938 - $44,209
2,311 Added 105.62%
4,499 $83,000
Q3 2023

Nov 14, 2023

SELL
$14.02 - $17.71 $29,666 - $37,474
-2,116 Reduced 49.16%
2,188 $30,000
Q2 2023

Aug 14, 2023

SELL
$17.0 - $21.58 $30,192 - $38,326
-1,776 Reduced 29.21%
4,304 $81,000
Q1 2023

May 15, 2023

BUY
$18.01 - $23.12 $95,453 - $122,536
5,300 Added 679.49%
6,080 $128,000
Q2 2022

Aug 15, 2022

SELL
$17.05 - $28.22 $6,308 - $10,441
-370 Reduced 32.17%
780 $17,000
Q1 2022

May 16, 2022

SELL
$19.62 - $29.61 $19,835 - $29,935
-1,011 Reduced 46.78%
1,150 $32,000
Q4 2021

Feb 14, 2022

BUY
$20.04 - $27.57 $12,104 - $16,652
604 Added 38.79%
2,161 $44,000
Q3 2021

Nov 15, 2021

BUY
$23.51 - $34.79 $8,063 - $11,932
343 Added 28.25%
1,557 $38,000
Q2 2021

Aug 16, 2021

BUY
$29.0 - $40.64 $35,206 - $49,336
1,214 New
1,214 $42,000

Others Institutions Holding XOMA

About XOMA Corp


  • Ticker XOMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,450,800
  • Market Cap $311M
  • Description
  • XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...
More about XOMA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.